The contribution of the peripheral immune system to neurodegeneration

F Berriat, CS Lobsiger, S Boillée - Nature Neuroscience, 2023 - nature.com
Microglial cells are the major immune cells of the central nervous system (CNS), and directly
react to neurodegeneration, but other immune cell types are also able to react to pathology …

[HTML][HTML] Masitinib: The promising actor in the next season of the Amyotrophic Lateral Sclerosis treatment series

AHME Ketabforoush, R Chegini, S Barati… - Biomedicine & …, 2023 - Elsevier
Abstract Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease with high
mortality and morbidity rate affecting both upper and lower motor neurons (MN). Muscle …

Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial

JS Mora, A Genge, A Chio, CJ Estol… - … Lateral Sclerosis and …, 2020 - Taylor & Francis
Objective: To assess masitinib in the treatment of ALS. Methods: Double-blind study,
randomly assigning 394 patients (1: 1: 1) to receive riluzole (100 mg/d) plus placebo or …

Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trial

B Dubois, J López-Arrieta, S Lipschitz, T Doskas… - Alzheimer's Research & …, 2023 - Springer
Background Masitinib is an orally administered tyrosine kinase inhibitor that targets
activated cells of the neuroimmune system (mast cells and microglia). Study AB09004 …

Modifying macrophages at the periphery has the capacity to change microglial reactivity and to extend ALS survival

A Chiot, S Zaïdi, C Iltis, M Ribon, F Berriat… - Nature …, 2020 - nature.com
Microglia and peripheral macrophages have both been implicated in amyotrophic lateral
sclerosis (ALS), although their respective roles have yet to be determined. We now show …

Oxidative stress, neuroinflammation and mitochondria in the pathophysiology of amyotrophic lateral sclerosis

E Obrador, R Salvador, R López-Blanch… - Antioxidants, 2020 - mdpi.com
Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron (MN) disease. Its primary
cause remains elusive, although a combination of different causal factors cannot be ruled …

Immunity in amyotrophic lateral sclerosis: Blurred lines between excessive inflammation and inefficient immune responses

LC Béland, A Markovinovic, H Jakovac… - Brain …, 2020 - academic.oup.com
Despite wide genetic, environmental and clinical heterogeneity in amyotrophic lateral
sclerosis, a rapidly fatal neurodegenerative disease targeting motoneurons …

Comprehensive research on past and future therapeutic strategies devoted to treatment of amyotrophic lateral sclerosis

B Sever, H Ciftci, H DeMirci, H Sever, F Ocak… - International journal of …, 2022 - mdpi.com
Amyotrophic lateral sclerosis (ALS) is a rapidly debilitating fatal neurodegenerative disorder,
causing muscle atrophy and weakness, which leads to paralysis and eventual death. ALS …

The roles of flavonols/flavonoids in neurodegeneration and neuroinflammation

Z Calis, R Mogulkoc, AK Baltaci - Mini Reviews in Medicinal …, 2020 - ingentaconnect.com
The inflammatory process in the human body is a physiological response involving many
cellular types and mediators. It results in scar formation to separate the damaged area from …

Microglial depletion prevents extracellular matrix changes and striatal volume reduction in a model of Huntington's disease

JD Crapser, J Ochaba, N Soni, JC Reidling… - Brain, 2020 - academic.oup.com
Huntington's disease is associated with a reactive microglial response and consequent
inflammation. To address the role of these cells in disease pathogenesis, we depleted …